Blue Box Health Inc.

the company develops and deploys biosensors with cloud-based analytics that uniquely improve the ability of an individual to partner with the medical care establishment in anticipating and preventing devastating decompensation events. the company has developed a prototype sensor, blue scale, for chronically ill heart failure patients' use in the home. the company has designed a clinical trial for the purpose of securing approval of its product by the fda. the blue scale will further the delivery of therapeutics by providing real-time monitoring and reporting as well as daily feedback thus improving medication compliance, decreasing complications, preventing decompensation events, and markedly decreasing the cost of care of this disease that accounts for $39 billion in direct costs. the system will reduce total rehospitalization costs in the u.s. by $6 billion.